Ends-in vs. ends-out recombination in yeast - PubMed (original) (raw)
Ends-in vs. ends-out recombination in yeast
P J Hastings et al. Genetics. 1993 Dec.
Abstract
Integration of linearized plasmids into yeast chromosomes has been used as a model system for the study of recombination initiated by double-strand breaks. The linearized plasmid DNA recombines efficiently into sequences homologous to the ends of the DNA. This efficient recombination occurs both for the configuration in which the break is in a contiguous region of homology (herein called the ends-in configuration) and for "omega" insertions in which plasmid sequences interrupt a linear region of homology (herein called the ends-out configuration). The requirements for integration of these two configurations are expected to be different. We compared these two processes in a yeast strain containing an ends-in target and an ends-out target for the same cut plasmid. Recovery of ends-in events exceeds ends-out events by two- to threefold. Possible causes for the origin of this small bias are discussed. The lack of an extreme difference in frequency implies that cooperativity between the two ends does not contribute to the efficiency with which cut circular plasmids are integrated. This may also be true for the repair of chromosomal double-strand breaks.
Similar articles
- Influence of non-homology between recombining DNA sequences on double-strand break repair in Saccharomyces cerevisiae.
Glasunov A, Frankenberg-Schwager M, Frankenberg D. Glasunov A, et al. Mol Gen Genet. 1995 Apr 10;247(1):55-60. doi: 10.1007/BF00425821. Mol Gen Genet. 1995. PMID: 7715604 - Induction of recombination between homologous and diverged DNAs by double-strand gaps and breaks and role of mismatch repair.
Priebe SD, Westmoreland J, Nilsson-Tillgren T, Resnick MA. Priebe SD, et al. Mol Cell Biol. 1994 Jul;14(7):4802-14. doi: 10.1128/mcb.14.7.4802-4814.1994. Mol Cell Biol. 1994. PMID: 8007979 Free PMC article. - [Role of the RAD57 gene in the repair of double-stranded DNA gaps in the yeast Saccharomyces cerevisiae].
Glazer VM, Glazunov AV. Glazer VM, et al. Genetika. 1997 Sep;33(9):1221-8. Genetika. 1997. PMID: 9445816 Russian. - Break-induced replication: a review and an example in budding yeast.
Kraus E, Leung WY, Haber JE. Kraus E, et al. Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8255-62. doi: 10.1073/pnas.151008198. Proc Natl Acad Sci U S A. 2001. PMID: 11459961 Free PMC article. Review. - Homologous recombination: ends as the means.
Ray A, Langer M. Ray A, et al. Trends Plant Sci. 2002 Oct;7(10):435-40. doi: 10.1016/s1360-1385(02)02327-0. Trends Plant Sci. 2002. PMID: 12399177 Review.
Cited by
- Heterologous expression of recombinant urate oxidase using the intein-mediated protein purification in Pichia pastoris.
Khaleghi R, Asad S. Khaleghi R, et al. 3 Biotech. 2021 Mar;11(3):120. doi: 10.1007/s13205-021-02670-6. Epub 2021 Feb 8. 3 Biotech. 2021. PMID: 33628707 Free PMC article. - The XPF-ERCC1 Complex Is Essential for Genome Stability and Is Involved in the Mechanism of Gene Targeting in Physcomitrella patens.
Guyon-Debast A, Rossetti P, Charlot F, Epert A, Neuhaus JM, Schaefer DG, Nogué F. Guyon-Debast A, et al. Front Plant Sci. 2019 May 9;10:588. doi: 10.3389/fpls.2019.00588. eCollection 2019. Front Plant Sci. 2019. PMID: 31143199 Free PMC article. - Effect of Plasmid Design and Type of Integration Event on Recombinant Protein Expression in Pichia pastoris.
Vogl T, Gebbie L, Palfreyman RW, Speight R. Vogl T, et al. Appl Environ Microbiol. 2018 Mar 1;84(6):e02712-17. doi: 10.1128/AEM.02712-17. Print 2018 Mar 15. Appl Environ Microbiol. 2018. PMID: 29330186 Free PMC article. - Gene Editing with Helper-Dependent Adenovirus Can Efficiently Introduce Multiple Changes Simultaneously over a Large Genomic Region.
Palmer DJ, Grove NC, Turner DL, Ng P. Palmer DJ, et al. Mol Ther Nucleic Acids. 2017 Sep 15;8:101-110. doi: 10.1016/j.omtn.2017.06.001. Epub 2017 Jun 7. Mol Ther Nucleic Acids. 2017. PMID: 28918012 Free PMC article. - Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer.
Proskurina AS, Gvozdeva TS, Alyamkina EA, Dolgova EV, Orishchenko KE, Nikolin VP, Popova NA, Sidorov SV, Chernykh ER, Ostanin AA, Leplina OY, Dvornichenko VV, Ponomarenko DM, Soldatova GS, Varaksin NA, Ryabicheva TG, Uchakin PN, Zagrebelniy SN, Rogachev VA, Bogachev SS, Shurdov MA. Proskurina AS, et al. BMC Cancer. 2015 Mar 13;15:122. doi: 10.1186/s12885-015-1142-z. BMC Cancer. 2015. PMID: 25886605 Free PMC article. Clinical Trial.
References
- J Theor Biol. 1976 Jun;59(1):97-106 - PubMed
- Genetics. 1979 Sep;93(1):51-65 - PubMed
- Mol Cell Biol. 1991 Sep;11(9):4509-17 - PubMed
- Bioessays. 1988 Aug-Sep;9(2-3):61-4 - PubMed
- Cold Spring Harb Symp Quant Biol. 1984;49:839-44 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases